Journals / Turkish Journal of Medical Sciences / 2011 / Cilt: 41 - Sayı: 4

Retrospective evaluation of laboratory-confirmed and recovered cases of influenza A(H1N1)v

Pages
647–656
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is believed that precautions such as hand-washing, limiting visits, and ensuring proper ventilation within houses will reduce in-house infectivity and the secondary attack rate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To retrospectively evaluate patients that were diagnosed with H1N1 and recovered from the disease in the initial period of an influenza A(H1N1)v epidemic in the province of Diyarbakir.
📊
Key Findings & Data:It is estimated that 34-67 million individuals around the world have been infected by influenza A(H1N1)v, that 154,000-303,000 individuals have been hospitalized, and that 7000-13,000 individuals have lost their lives.
💡
Conclusion & Impact:It is believed that precautions such as hand-washing, limiting visits, and ensuring proper ventilation within houses will reduce in-house infectivity and the secondary attack rate.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Key words: Influenza (H1N1)v · retrospective study · Diyarbakır

Abstract

To retrospectively evaluate patients that were diagnosed with H1N1 and recovered from the disease in the initial period of an influenza A(H1N1)v epidemic in the province of Diyarbakir. It is estimated that 34-67 million individuals around the world have been infected by influenza A(H1N1)v, that 154,000-303,000 individuals have been hospitalized, and that 7000-13,000 individuals have lost their lives. Materials and methods: We were able to include 250 of 362 cases (69.0%) of confirmed influenza A(H1N1)v, from which the patients recovered, from the samples received between 19 October and 3 December 2009 after a pandemic alarm was given in the province of Diyarbakır. Patients with laboratory-confirmed cases were reached by telephone 15 days after the onset of influenza symptoms. Results: In terms of demographics, 44.8% of patients were between the ages of 0-14, 51.6% were male, and 44.0% were students. In 77.6% of the cases, fever was observed, while 53.2% had coughs and 18.4% had vomiting problems. It was determined that patients older than 45 years old, pregnant women, and individuals with chronic diseases were hospitalized more frequently than the young, nonpregnant women, and individuals without a chronic disease. The secondary attack rate within the clinic was 24.6%. Conclusion: Children and individuals with chronic diseases are important risk groups. It is believed that precautions such as hand-washing, limiting visits, and ensuring proper ventilation within houses will reduce in-house infectivity and the secondary attack rate.

Özet

To retrospectively evaluate patients that were diagnosed with H1N1 and recovered from the disease in the initial period of an influenza A(H1N1)v epidemic in the province of Diyarbakir. It is estimated that 34-67 million individuals around the world have been infected by influenza A(H1N1)v, that 154,000-303,000 individuals have been hospitalized, and that 7000-13,000 individuals have lost their lives. Materials and methods: We were able to include 250 of 362 cases (69.0%) of confirmed influenza A(H1N1)v, from which the patients recovered, from the samples received between 19 October and 3 December 2009 after a pandemic alarm was given in the province of Diyarbakır. Patients with laboratory-confirmed cases were reached by telephone 15 days after the onset of influenza symptoms. Results: In terms of demographics, 44.8% of patients were between the ages of 0-14, 51.6% were male, and 44.0% were students. In 77.6% of the cases, fever was observed, while 53.2% had coughs and 18.4% had vomiting problems. It was determined that patients older than 45 years old, pregnant women, and individuals with chronic diseases were hospitalized more frequently than the young, nonpregnant women, and individuals without a chronic disease. The secondary attack rate within the clinic was 24.6%. Conclusion: Children and individuals with chronic diseases are important risk groups. It is believed that precautions such as hand-washing, limiting visits, and ensuring proper ventilation within houses will reduce in-house infectivity and the secondary attack rate.

🔖

Cite This Article

ALBAYRAK, N., SEVENCAN, F., DORMAN, V., ERTEM, M. M., ÖZÇULLU, N., ORMANLI, A., KUBAT, N. K., ALTAŞ, A. B. (2022). Retrospective evaluation of laboratory-confirmed and recovered cases of influenza A(H1N1)v. Turkish Journal of Medical Sciences, Cilt: 41 - Sayı: 4, 647–656. https://ajindex.com/articles/611360

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Yu H, Zhou YJ, Li GX, Zhang GH, Liu HL, Yan LP et al. Further evidence for infection of pigs with human-like H1N1 infl uenza viruses in China. Virus Research 2009; 140: 85-90. CDC. Swine infl uenza A(H1N1) infection in two children - Southern California, March-April 2009. MMWR 2009; 58: 400-2.
  2. Garten RJ, Davis CT, Russel CA. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) infl uenza viruses circulating in humans. Science 2009; 325: 197-201.
  3. Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 infl uenza A(H1N1) virus. N Eng J Med 2009; 361: 115-19. Fitzgerald DA. Human swine infl uenza A (H1N1): Practical advice for clinicians early in the pandemic. Paediatric Respiratory Reviews 2009; 10: 154-58. CDC. Novel H1N1 fl u situation update July 10, 2009. 2009. http://www.cdc.gov/h1n1fl u/updates/071009.htm (Accessed July 22, 2009). CDC. Novel H1N1 fl u situation update June 12, 2009. 2009. http://www.cdc.gov/h1n1fl u/updates/061209.htm (Accessed July 22, 2009). European Centre for Disease Prevention and Control. Pandemic H1N1 2009 risk assessment. http://www.ecdc. europa.eu/en/healthtopics/documents/0908_influenza_ ah1n1_risk_assessment.pdf (Accessed November 6, 2009). Statement to the press by WHO Director General Dr. Margaret Chan, http://www.who.int/media-centre/news/ statements/2009/h1n1-pandemic-qhases6-20090611/en/ indew.html (Accessed December 12, 2009).
  4. White LF, Walling J, Finelli L, Reed C, Riley S, Lipsitch M et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 infl uenza A/H1N1 pandemic in the USA. Infl uenza and Other Respiratory Viruses 2009; 3: 267-76. CDC estimates of 2009 H1N1 infl uenza cases, hospitalizations and deaths in the United States, April-November 14, 2009. http://cdc.gov/h1n1fl u/estimates_2009_h1n1.htm (Accessed January 04, 2010). Wiwanitkit V. Finding a new drug and vaccine for emerging swine fl u: What is the concept? Biologics: Targets & Th erapy 2009; 3: 377-83.
  5. Cheng PKC, Wong KKY, Mak GC, Wong AH, Ng AYY, Chow SYK et al. Performance of laboratory diagnostics for the detection of infl uenza A(H1N1)v virus as correlated with the time aft er symptom onset and viral load. Journal of Clinical Virology 2010; 47: 182-85.
  6. Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ, Grajales-Muniz C, Robles-Perez E, Gonzalez-León M et al. Infection and death from infl uenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 37